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1995). Because these mice are homozygously mutant for
p53, a mechanism involving environmental teratogens
Summary (Nicol et al., 1995) or somatic events in additional genes
must be postulated to explain the appearance of exen-
The nevoid basal cell carcinoma syndrome (NBCCS) cephaly in some embryos but not in others.
is an autosomal dominant disorder characterized by The nevoid basal cell carcinoma syndrome (NBCCS),
multiple basal cell carcinomas (BCCs), pits of the also known as Gorlin syndrome and the basal cell nevus
palms and soles, jaw keratocysts, a variety of other syndrome, is an autosomal dominant disorder that pre-
tumors, and developmental abnormalities. NBCCS disposes to both cancer and developmental defects
maps to chromosome 9q22.3. Familial and sporadic (Gorlin, 1995). Its prevalence has been estimated at 1
BCCs display loss of heterozygosity in this region, per 56,000, and 1%±2% of medulloblastomas and 0.5%
consistent with the gene being a tumor suppressor. A of basal cell carcinomas (BCCs) are attributable to the
human sequence (PTC) with strong homology to the syndrome (Springate, 1986; Evans et al., 1991). In addi-
Drosophila segment polarity gene, patched, was iso- tion to BCCs and medulloblastomas, NBCCS patients
lated from a YAC and cosmid contig of the NBCCS are also at an increased risk for ovarian fibromas, menin-
region. Mutation analysis revealed alterations of PTC giomas, fibrosarcomas, rhabdomyosarcomas, cardiac
fibromas, and ovarian dermoids (Evans et al., 1991,
1993; Gorlin, 1995). Nonneoplastic features including9 These authors contributed equally to thiswork and are listed alpha-
betically. odontogenic keratocysts (which are most aggressive in
Cell
842
the second and third decades of life), pathognomonic (Figure 1). Most hereditary tumors with allelic loss de-
leted the entire region between the flanking markers.dyskeratotic pitting of the hands and feet, and progres-
sive intracranial calcification (usually evident from the However, one hereditary cardiac fibroma showed loss
at D9S287 but not D9S280 on the nondisease-carryingsecond decade) are very common. There is a broad
range of skeletal defects (Gorlin, 1995; Shanley et al., allele, suggesting that the gene is located distal to
D9S280. In sporadic BCCs, four tumors were found that1994) including rib, vertebral and shoulder anomalies,
pectus excavatum, immobile thumbs, and polydactyly. retained D9S287 and lost more distal markers, sug-
gesting that the gene is distal to D9S287, in conflict withCraniofacial and brain abnormalities include cleft palate,
characteristic coarse facies, strabismus, dysgenesis of findings from linkage analysis. In addition, we also saw
two tumors that lost the proximal marker D9S280 butthe corpus callosum, macrocephaly, and frontal bossing
(Gorlin, 1995). Generalized overgrowth (Bale et al., 1991) not D9S287, consistent with the linkage data. Several
hypotheses can be proposed to explain these discrep-and acromegalic appearance are common, but growth
hormone and IGF1 levels are not elevated. ancies, including the existence of a second gene re-
sponsible for the allelic loss in some sporadic tumors.Implications for the affected individual can be severe,
predominantly due to the prolific BCCs, which can num- Taken together, our data suggested that the most likely
location of the NBCCS gene was between markersber more than 500 in a lifetime (Shanley et al., 1994).
Expression of many features of the syndrome are vari- D9S280 and D9S287. Nevertheless, physical mapping
and cDNA isolation was undertaken in the entire regionable, both within and between families (Anderson et al.,
1967; unpublished data). This variation between families between D9S196 and D9S180.
mayreflect specific phenotypic effects of different muta-
tions, modifier genes, or environmental factors (sunlight
Physical Mappingexposure is likely to play a role in the age of onset and
We obtained 29 yeast artificial chromosomes (YACs)incidence of BCCs). One-third to one-half of patients
containing markers from this region from the CEPHhave no affected relatives and are presumed to be the
megaYAC library, and 18 formed an overlapping contigproduct of new germ cell mutations (Gorlin, 1995). Uni-
between D9S196 and D9S180 with at least 2-fold redun-lateral and segmental NBCCS are probably attributable
dancy. Based on this contig, the minimum distance be-to somatic mutation in one cell of an early embryo (Gut-
tween the flanking markers was 1.5 Mb, but virtually allierrez and Mora, 1986).
large YACs had internal deletions as judged by se-Mapping of the gene for this syndrome (NBCCS) to
quence-tagged site content. Additional YACs were ob-chromosome 9q22±31 (Gailani et al., 1992; Reis et al.,
tained fromthe ICI library to provide redundancy in areas1992; Farndon et al., 1992) and the demonstration that
apparently prone to deletion. Cosmid and bacterial ar-the same region is deleted in a high percentage of BCCs
tificial chromosome (BAC) contigs were constructedand other tumors related to the disorder (Gailani et al.,
around known sequence-tagged sites and genes, and1992) provided strong evidence that the gene functions
additional cosmids from the region were isolated byas a tumor suppressor. Inactivation of this gene may be
hybridizing YACs to the Lawrence Livermore griddeda necessary if not sufficient event for the development
cosmid library. In total, over 800 cosmids specific toof BCCs (Shanley et al., 1995; Gailani et al.; 1996, Holm-
this region were gridded into 96-well plates, and contigsberg et al., 1996).
of BACs, P1s, and cosmids covering 1.5 Mb were con-
structed (Figure 1). Because of deletions in YACs and
Results some gaps in the cosmid and BAC contig, pulsed-field
gel electrophoresis (PFGE) and fluorescence in situ hy-
Fine Mapping by Linkage and Tumor bridization (FISH) were used to integrate the cloned
Deletion Studies regions. Based on the sizes of restriction fragments in
Since the original mapping of the gene in 1992, linkage this region and FISH estimates, the physical distance
studies have narrowed the NBCCS region to a 4 cM from D9S180 to D9S196 was estimated at not less than
interval between D9S180 and D9S196 (Goldstein et al., 2 Mb.
1994; Wicking et al., 1994). Farndon et al. (1994) reported
recombination involving an unaffected individual that
tentatively placed the gene proximal to D9S287. In addi- Isolation of cDNAs
Several methods were used to find genes that map totion, we identified one recombination between D9S287
and the Fanconi's anemia complementation group C chromosome 9q22, including sample sequencing of
cosmids, exon trapping, CpG island cloning, and direct(FACC) gene in a three-generation family that would
place the gene proximal to D9S287. The recombinant selection of cDNAs from BACs and cosmids. In addition,
genes known to lie in this general area were more finelyindividual was a one-and-a-half-year-old female pre-
sumed to be affected on the basis of macrocephaly, mapped by use of somatic cell hybrids made from two
NBCCS patients with visible 9q22 deletions (submittedstrabismus, and frontal bossing. Some of the key fea-
tures of the syndrome, such as BCCs, jaw cysts, and to the National Institute of General Medical Sciences
repository), YAC contigs, and FISH. Ten genes, ten ex-palmar pits, were lacking, but these features have age-
dependent expression, and their presence in a young pressed sequence tags (ESTs) with sequences in Gen-
Bank, and 31 anonymously selected cDNA fragments,child would not be expected.
Allelic loss in BCCs was concordant with linkage map- CpG island clones, and trapped exons with no known
homology were identified (Table 1).ping in placing the gene between D9S196 and D9S180
Patched Mutations in NBCCS
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Figure 1. Integrated Framework Map of the NBCCS Region
Both linkage and tumor deletion studies place NBCCS between D9S196 and D9S180 but are conflicting with regard to whether the gene lies
proximal or distal to D9S287 (discussed in text). The order of six polymorphic markers, D9S197, D9S196, D9S280, FACC, D9S287, D9S180,
is derived from genetic linkage data (Farndon et al., 1994; Pericak-Vance et al., 1995). D9S196 and D9S197 show no measurable recombination.
PFGE and FISH give a minimum distance of 2 Mb between D9S196 and D9S180. Key information about YAC, BAC, and cosmid contigs in
the NBCCS region is shown. In total, 22 overlapping YACs and more than 800 cosmids were isolated from this region. BAC and cosmid
contigs covering more than 1.2 Mb have been submitted to the Genome Data Base.
Screening Patients for Germline Deletions available for study, but the third patient was a sporadic
case of NBCCS, and neither parent had the SacII alter-or Rearrangements
Because chromosome 9q22 appeared to be very gene ation. The finding of this variant in a patient but not in
her parents could be interpreted as the result of hyper-rich, an attempt was made to localize the NBCCS gene
more precisely by searching for submicroscopic re- mutability of some CG-rich region near FACC, but no
variation in this region was identified in PFGE blots ofarrangements in patients. We hybridized 15 cosmids at
approximately 100±200 kb intervals spanning the region over 100 normal chromosomes.
between D9S196 and D9S180 to PFGE blots of 82 unre-
lated NBCCS patients. In addition, probes from genes
known to map to the interval as well as those identified Evaluation of PTC as a Candidate Gene
Because variant PFGE bands were identified near FACCin the course of the study were included in this analysis.
PFGE variants were identified in three patients with and linkage and tumor data suggested this region as a
likely location, we evaluated cDNAs that mapped to thisprobes from within the FACC gene. All three were het-
erozygous for SacII bands approximately 30 kb shorter area. FACC, itself, was not considered a candidate be-
cause heterozygous mutations in this gene do not causethan normal (310 kb versus 280 kb). The limit of resolu-
tion of PFGE was about 10 kb, so that it was not possible NBCCS (Strathdee et al., 1992). FACC and PTC (a human
gene with strong homology to Drosophila patched [ptc])to determine whether the apparently identical variant
SacII bands were exactly thesame size. Other restriction hybridized to the same 650 kb NotI fragment and 675 kb
and 1000 kb (partial) MluI fragments.Mouse interspeciesenzymes, including NotI, BssHII, MluI, SfiI, and NruI,
did not show variant bands. The variations were not backcross analysis determined that there were no re-
combinants between the PTC and FACC genes out ofconsistent with germline deletions in these patients but
could conceivably be caused by point mutations creat- 190 meioses (Hahn et al., 1996a). PTC and D9S287 were
both present on ICI YAC 2EF8, having a size of 350 kb,ing new restriction sites or other small alterations, such
as the recurrent inversions seen in the F8C gene of many strongly suggesting that PTC lies between D9S287 and
FACC.hemophiliacs (Lakich et al., 1993).
The nature of the DNA alterations causing these To screen for mutations in the PTC gene, the intron/
exon boundaries of the gene were determined from ge-changes on PFGE has not yet been elucidated, but the
data relating them to the disease are compelling. The nomic clones and long-range polymerase chain reaction
(PCR) products. PTC consists of 23 exons and the genefamilies of two of the patients with variations were not
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(primers used for amplification of PTC exons are shownTable 1. cDNA Clones from the NBCCS Region on Chromosome
9q22.3 in Table 2). Patients displaying variations were com-
pared with unaffected individuals of the same race, andClone Designationa Clone Typeb
variants found only in affected individuals were further
cDNAs previously mapped to chromosome 9q and more finely characterized by DNA sequencing. Of the mutations
mapped with somatic cell hybrids, PGFE, and YAC contigs
identified in unrelated patients, four were deletions orFACC Gene
insertions resulting in frameshifts and two were pointNCBP Gene
mutations leading to premature stops (Table 3; Figures 3HSD17B3 Gene
TMOD Gene and 4). An additional finding confirming the relationship
XPA Gene between mutations in PTC and the disease was identifi-
SYK Gene cation of a frameshift mutation in a sporadic NBCCS
WI-11139 EST (R14225)
patient that was not present in either of her unaffectedWI-11414 EST (T88697)
parents (Figure 4).WI-8684 EST (R14413)
To analyze the role of PTC in neoplasia, tumors relatedD9S1697 EST (R06574)
D9S1145 EST (contains R17127 and Z38405) to the syndrome were screened for mutations. Two spo-
radic BCCs with allelic loss of the NBCCS region hadNovel clones or clones not previously mapped to chromosome 9q
inactivating mutations of the remaining allele (Table 3;identified by sample sequencing, exon trapping, HTF island cloning
or cDNA selection Figures 5 and 6). A tumor removed from the cheek had
ZNF169 Gene a CC to TT alteration, typical of ultraviolet B mutagene-
FBP1 Gene sis. The second tumor from the nose had a 14 bp dele-
PTC Gene
tion, a mutation that cannot be related to any specificCoronin homolog Gene
environmental agent. Mutations have not yet been iden-2F1a EST (R39928)
tified in any sporadic BCC not showing allelic loss of2F1b EST (T11435)
11F21 EST (Z43835) chromosome 9q22, and alternative modes of pathogen-
31F3 EST (R16281) esis may be operative in these tumor types.
yo20g05.s1 EST (Merck EST)
Plus 31 anonymous selected cDNA fragments, HTF island clones,
Discussionand trapped exons from YACs and cosmid poolsc
aFor known genes and anonymous cDNAs that have been submitted
Tumorigenesis in humans is a multistep process involv-to the Genome Data Base (http://gdbwww.gdb.org/gdb), standard
ing activation of oncogenes and inactivation of tumorlocus nomenclature is used. For ESTs without a GDB number, WI
indicates a Whitehead Institute clone (http://www-genome.wi. suppressor genes. Genetic analysis of hereditary cancer
mit.edu). predisposition syndromes has been critical in elucidat-
bGenBank accession numbers, where available, are given in paren- ing the nature of tumor suppressors. The gene underly-
theses for anonymous ESTs. Additional information can be obtained
ing hereditary predisposition to retinoblastoma (RB1)at http://www.ncgr.org/gsdb.
(Friend et al., 1986) was the first of this class to becAdditional sequence data will be required to determine whether
isolated. RB1 and several other tumor suppressors func-some of the anonymous cDNAs represent different portions of the
same genes. tion in the nucleus to regulate transcription and the cell
cycle (Weinberg, 1995b). Increasing evidence indicates
that modulation of proliferation and differentiation may
also take place at the cell membrane. Tumor suppres-spans approximately 34 kb (Figure 2). Panels of unre-
lated NBCCS patients and BCCs were screened by sin- sors with presumed functions in intercellular adhesion
and signaling include DCC (Fearon et al., 1990), APCgle strand conformation polymorphism (SSCP) analysis
Figure 2. Map of the PTC Locus
The gene lies on four overlapping cosmids including 226G7, 42H11, 55A16, and 96F9 (LL09NC01, 96-well coordinates). The coding exons of
the gene are shown as closed boxes and noncoding exons as open boxes. Splice variants of the 59 noncoding region of the gene indicate
at least two alternate first exons and possibly a third alternate exon (see Discussion).
Patched Mutations in NBCCS
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Table 2. Primers to Amplify PTC Exons
Exon Positiona Exon Size (bp) Primersb
1 1-189 189 PTCF18 GAAGG CGAGC ACCCA GAC
PTCR18 TCTTT CCCTC CTCTC CCTTC
1A Alternate .239 PTCF22 GCTAT GGAAA TGCGT CGG
First exon PTCR22 CAGTC CTGCT CTGTC CATCA
2 190-382 193 PTCF19 GTGGC TGAGA GCGAA GTTTC
PTCR19 TTCCA CCCAC AGCTC CTC
3 383-582 200 PTCF27 CTATT GTGTA TCCAA TGGCA GG
PTCR27 ATTAG TAGGT GGACG CGGC
4 583-642 60 PTCF20 GAG AAATTTTTGTCTCTGCTTTTCA
PTCR20 CCTGA TCCAT GTAAC CTGTT TC
5 643-734 92 PTCF21 GCAAA AATTT CTCAG GAACACC
PTCR21 TGGAA CAAAC AATGA TAAGCAA
6 735-933 199 PTCF15 CCTAC AAGGT GGATG CAGTG
18R2 TTTGC TCTCC ACCCT TCTGA
7 934-1055 122 11e18F GTGAC CTGCC TACTA ATTCCC
18R3 GGCTA GCGAG GATAA CGGTTTA
8 1056-1203 148 PTCF2 GAGGC AGTGG AAACT GCTTC
PTCR2 TTGCA TAACC AGCGA GTCTG
9 1204-1335 132 PTCF23 GTGCT GTCGA GGCTT GTG
PTCR23 ACGGA CAGCA GATAA ATGGC
10 1336-1492 157 PTCF23 GTGCT GTCGA GGCTT GTG
PTCR23 ACGGA CAGCA GATAA ATGGC
11 1493-1591 97 PTCF5 GTGTT AGGTG CTGGT GGCA
PTCR5 CTTAG GAACA GAGGA AGCTG
12 1591-1835 245 PTCF24 TCTGC CACGT ATCTG CTCAC
PTCR24 CATGC TGAGA ATTGC AGGAA
13 1836-2238 403 PTCF16 GGCCT ACACC GACAC ACAC
PTCR16 TTTTT TTGAA GACAG GAAGA GCC
PTC13R GTCAG CAGAC TGATT CAGGT
PTC37R AAGAT GAGAG TGTCC ACTTCG
14 2239-2548 310 PTCF14 GACAG CTTCT CTTTG TCCAG
PTCR14 ACGCA AAAGA CCGAA AGGAC GA
15 2549-2691 143 PTCF13 AGGGT CCTTC TGGCT GCGAG
PTCR13 TCAGT GCCCA GCAGC TGGAG TA
16 2692-2875 185 PTCF7 AACCC CATTC TCAAA GGCCTCTGTTC
PTCR7 CACCT CTGTA AGTTC CCAGA CCT
17 2876-3156 281 PTCF12 AACTG TGATG CTCTT CTACC CTGG
PTCR12 AAACT TCCCG GCTGC AGAAA GA
18 3157-3294 138 PTCF8 TTTGA TCTGA ACCGA GGACACC
PTCR8 CAAAC AGAGC CAGAG GAAATGG
19 3295-3437 143 PTCF11 TAGGA CAGAG CTGAG CATTT ACC
PTC21R TACCT GACAA TGAAG TCG
20 3437-3537 101 PTCF11 TAGGA CAGAG CTGAG CATTT ACC
PTC21R TACCT GACAA TGAAG TCG
21 3538-3792 255 PTCF25 AACAG AGGCC CCTGA AAAAT
PTCR25 GATCA CTTGG TGGGC AGG
22 3793-4330c 537 PTCF10 TCTAA CCCAC CCTCA CCCTT
PTC31R ATTGT TAGGG CCAGA ATGCC
PTCF26 AGAAA AGGCT TGTGG CCAC
PTCR26 TCACC CTCAG TTGGA GCTG
aPositions of exons are shown in bp according to the numbering of the human cDNA sequence. The size of the exon is known in all cases
except for exon 1A, for which the 59 end is not yet defined.
bThe sequence of the primers is 59-39. There is an approximately 600 bp intron between exons 9 and 10 (primers F23 and R23), and a 45 bp
intron between exons 18 and 19 (primers F11 and 21R). Updated primer sequences and PCR conditions will be available by anonymous FTP
(contact dean@fcrfv1.ncifcrf.gov).
cPosition of the last bp of the final codon.
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Table 3. Mutations in the PTC Gene
Sample Typea Inheritanceb Exon Type of Mutation Designation
NBCCS F 8 Premature stop C1081T
NBCCS F 6 37 bp deletion del 804-840
NBCCS F 8 Premature stop G1148A
NBCCS F 13 2 bp insertion 2047insCT
NBCCS S 13 1 bp insertion 2000insC
NBCCS S 15 1 bp deletion 2583delC
BCC S 8 Premature stop CC1081TT
BCC S 16 14 bp deletion del 2704-2717
aNBCCS, germline mutations in a patient with the syndrome; BCC, somatic mutation in a basal cell carcinoma.
bF, familial; S, sporadic.
(Rubinfeld et al., 1993; Su et al., 1993), and NF2 (Trofatter 1990). Genetic and functional studies have shown that
one of the wild-type functions of ptc is transcriptionalet al., 1993).
Our current study providesstrong evidence that muta- repression of members of the Wnt and TGFb gene fami-
lies (Ingham et al., 1991; Capdevila et al., 1994). Thetions of the human homolog of Drosophila ptc cause
NBCCS. Alterations predicted to inactivate the PTC mechanism of this repression is not known, and several
downstream targets of ptc activity may exist. The actiongene product were found in six unrelated NBCCS pa-
tients. Frameshift mutations were found in two sporadic of ptc is opposed by the hedgehog (hh) gene, which
encodes a secreted glycoprotein that acts to transcrip-patients but not in their parents, and somatic mutations
were identified in two sporadic tumors of the types seen tionally activate both ptc-repressible genes and ptc it-
self (Tabata and Kornberg, 1994; Basler and Struhl,in the syndrome.
1994). Thus, in a given cell type the activity of target
genes results from a balance between hh signaling fromThe Drosophila ptc Gene in Differentiation
and Development adjacent cells and ptc activation.
The patched gene is part of a signaling pathway that is
conserved in eukaryotic organisms (Goodrich et al.,
1996; Hahn et al., 1996a). The Drosophila gene (ptc) Mammalian Homologs of ptc
We isolated a human homolog (PTC) of Drosophila ptcencodes a transmembrane glycoprotein that plays a role
in segment polarity (Hooper and Scott, 1989; Nakano et by sequence-sampling cosmids from the NBCCS re-
gion. The gene displays up to67% identity at the nucleo-al., 1989). Many alleles of ptc produce an embryonic
lethal phenotype with mirror-image duplication of seg- tide level and 60% similarity at the amino acid level to
the Drosophila gene (Hahn et al., 1996a). The identifica-ment boundaries and deletion of the remainder of the
segments (NuÈsslein-Volhard and Wieschaus, 1980), but tion of a human homolog would have beendifficult either
using a hybridization approach or by screening an ex-hypomorphic alleles produce viable adults with over-
growth of the anterior compartment of the wing, loss of pression library with antibodies to the Drosophila pro-
tein. Goodrich et al. (1996) were able to isolate a murinecostal structures, and wing vein defects (Phillips et al.,
Figure 3. Segregation of a Premature Termi-
nation Mutation of PTC in an NBCCS Ped-
igree
The C1081T (Q210X) mutation segregating in
this kindred creates a BfaI site. PCR with
flanking primers produces a 260 bp product,
which digests to 171 bp and 90 bp fragments
in affected family members. The PCR prod-
uct remains undigested in unaffected family
members.
Patched Mutations in NBCCS
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Figure 5. An Ultraviolet B-Induced Mutation of PTC in a Sporadic
BCC
(A) CC to TT mutation in the remaining allele of a tumor with allelic
loss of the NBCCS region. This DNA alteration, which results in a
premature stop, is typical of ultraviolet B mutagenesis.
(B) Constitutional DNA from the patient has a normal sequence.
(Hahn et al., 1996a; Goodrich et al., 1996) strongly sug-
gest that patched is a single copy gene in mammals.
Analysis of fetal brain cDNA clones, RACE (rapid am-
plification of cDNA ends) experiments with epidermal
RNA, and genomic sequencing revealed the presence
of three different 59 ends for the human PTC gene (Figure
2; data not shown). Two of the human alternative first
exons diverge from the mouse Ptc cDNA at the same
position, and the third is highly homologous to the
mouse N-terminus. The mouse N-terminus most closely
matches the N-terminus of the Drosophila gene and
a related Caenorhabditis elegans sequence (GenBank
accession number Z46812). These data suggest that
there are at least three different forms of the PTC protein
in mammalian cells: the ancestral form represented by
the murine sequence, and the two human forms. The
first in-frame methionine codon for one of the human
forms is in the third exon, suggesting that this form
of the mRNA either encodes an N-terminally truncated
protein or uses an alternate initiation codon. The second
human form contains an open reading frame that ex-
tends through to the 59 end and may be initiated by
upstream sequences that have not yet been isolated.
The third form contains an in-frame methionine codon
at a position conserved with the predicted initiation co-
don in the mouse (Goodrich et al., 1996). Additional
characterization of the PTC 59 end is required to resolve
Figure 4. A Frameshift Mutation of PTC in a Sporadic NBCCS Pa- the location of the start site in the different forms of
tient human PTC. The identification of several potential forms
(A) Both parents (1 and 2) of an affected individual (3) were free of of the PTC protein provides a mechanism whereby a
phenotypic features of NBCCS. single PTC gene could play a role in different pathways.
(B) The patient was heterozygous for an SSCP variant in exon 13
It will be important to determine the regulation of thethat was not present in her parents, and sequencing of a PCR
different splice forms of Ptc mRNA, as this may shedproduct from genomic DNA showed two sequences out of frame
light on the apparent role of the gene in both embryonicfollowing base 2000 (data not shown). The abnormal conformer was
sequenced and contained a 1 bp insertion (2000insC), resulting in development and growth control of adult cells.
a premature stop 9 amino acids downstream. Sequences of PCR
products from both parents were normal. The Role of PTC in Neoplasia
The data presented in this study strongly support earlier
observations (Gailani et al., 1992) suggesting that the
patched gene (Ptc) utilizing degenerate primers to con- NBCCS gene functions as a tumor suppressor. We pre-
served domains of the Drosophila sequence. Hydropa- viously demonstrated that hereditary tumors display
thy plots of the human and Drosophila sequence show loss of the wild-type homolog of the NBCCS region.
remarkable similarity and predict the presence of 8±12 Here, we show that the germline mutations detected
to date are inactivating and that, therefore, hereditarytransmembrane domains. Both human and mouse data
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Figure 6. A PTC Deletion in a Sporadic BCC
(A) A 14 bp deletion in the remaining allele of
a tumor with allelic loss of the NBCCS region.
Despite the fact that this tumor was removed
from the nose, a highly sunlight-exposed
area, the mutation cannot be related specifi-
cally to ultraviolet radiation.
(B) Constitutional DNA had the normal se-
quence.
tumors have no functional copy of the gene. In addition, with the presumed sites of expression of PTC in the
developing human embryo (Table 4). However, underthis report provides direct evidence that sporadic BCCs
can arise with somatic loss of both copies of the gene. the classical two-hit model for the action of tumor sup-
pressors (Knudson, 1971), the finding of developmentalThe role of PTC alterations in other tumor types associ-
ated with NBCCS, such as medulloblastoma, remains defects in a syndrome caused by hemizygous inactiva-
tion of this type of gene constitutes a paradox, becauseto be explored.
That two known targets of ptc repression in Drosoph- loss of one copy is thought to have little or no effect on
cell function.ila represent gene families involved in cell±cell commu-
nication and cell signaling provides a possible mecha- It is possible that some of the discrete defects in
NBCCS (e.g., spina bifida occulta, bifid ribs, and jawnism by which ptc could function as a tumor suppressor.
The ptc pathway has recently been implicated in tumori- cysts) can be explained by a two-hit mechanism. Like
the neoplasms in cancer predisposition syndromes,genesis by the cloning of the pancreatic tumor suppres-
sor gene, DPC4 (Hahn et al., 1996b), which shows se- many of these defects are multiple and appear in a
random pattern. However, isolated defects of the samequence similarity to Drosophila mothers against dpp
(mad). The mad gene interacts with dpp, a Drosophila type are seen occasionally in the general population.
These anomalies might result from homozygous inacti-TGFb homolog specifically repressed by ptc.
vation of PTC in an early progenitor cell of the relevant
tissue, leading to either abnormal migration, abnormalThe Role of PTC in Developmental Anomalies
During murine development, Ptc is initially detected differentiation, or failure to undergo programmed cell
death. Allelic loss studies have shown that keratocystswithin the somites and ventral neural tube and later in
the posterior ectoderm of each limb bud. Other sites of of the jaw are clonal abnormalities that arise with homo-
zygous inactivation of the NBCCS gene (Levanant etexpression include the pharyngeal arches, cells sur-
rounding the placodes of the vibrissae, and the genital al., 1996). However, generalized or symmetric features,
such as overgrowth, macrocephaly, and facial dysmor-eminence (Hahn et al., 1996a). In the mouse, expression
of Ptc is linked to expression of the vertebrate homologs phology, defy the two-hit paradigm and probably result
from perturbation of a dosage-sensitive pathway duringof Drosophila hh such that the transcripts are found
mostly in adjacent nonoverlapping tissues (Goodrich et embryonic development.
NBCCS is unusual among autosomaldominant canceral., 1996). Sonic hedgehog (Shh) is detected in the noto-
chord and the overlying floorplate region of the neural predisposition syndromes for its prominent develop-
mental defects. No known tumor suppressor gene hastube (Echelard et al., 1993). Apart from being involved
in midline signaling in vertebrates, Shh is also expressed sequence similarity to PTC, and, functionally, PTC may
represent a new type of neoplasia-related gene. Furtherin the developing limbs, where it appears to mediate
the activity of the zone of polarizing activity (Riddle et characterization of the protein product and its interac-
tion with HH should yield important information on theal., 1993).
Many of the features of NBCCS can be correlated link between differentiation and growth control.
Experimental Procedures
Table 4. Mouse Ptc Expression and Human NBCCS Phenotype
Subjects and Samples
Site of Expression in Mouse NBCCS Phenotype DNA samples were collected from 363 individuals in 128 NBCCS
kindreds. Patients were examined by a clinical geneticist, and diag-Pharyngeal arches Facial malformations
nosis of Gorlin syndrome was based on at least two major featuresJaw cysts
of the syndrome, e.g., jaw cysts, palmar pits, multiple BCCs, or a(dental lamima derivative)
family history of typical Gorlin syndrome. Lymphoblastoid cell linesCleft palate
were made from at least one affected member of 82 kindreds. A total
Neural tube Dysgenesis of the corpus of 252 BCCs were collected as either fresh or paraffin-embedded
callosum specimens.
Eye anomalies
Somites Spina bifida Short Tandem Repeat Polymorphisms
PCR reactions were performed in 50 ml volumes containing 100 ngVertebral fusion
Rib anomalies of template DNA, 200 mM dNTPs, 1.5 mM MgCl2, 0.25 mM spermi-
dine, 10 pM of each primer, 1 mCi [a-32P]dCTP (Amersham), andLimb buds Short fourth metacarpals
1.25 U Taq polymerase (Promega) in Promega buffer (10 mM TrisPolydactyly
HCl [pH 9], 50 mM KCl, 0.1% Triton X-100). An Ericomp Dual Block
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thermocycler was set with the following parameters for 25 cycles: Trapped DNAs were sequenced and mapped back to the NBCCS
candidate region by hybridization to the cosmids from which they948C for 1 min; 558C for 30 s; 728C for 2 min. PCR products were
analyzed on 5% polyacrylamide gels, and exposed at 2708C with were derived.
For CpG island cloning, YACs were size-fractionated by PFGE,Kodak XAR film. Loci are shown in Figure 1, and primer sequences
are available from the Genome Data Base (http://gdbwww.gdb.org). excised from the gel, and digested with BssHII. Subsequently, vect-
orette linkers were added and PCR amplification was performed
using a vectorette primer and a 59 Alu primer (Valdes et al., 1994).PFGE
After an initial denaturation at 1008C for 5 min, 30 amplificationCultured lymphoblastoidcells were embedded in LMP agarose (Bio-
cycles wereperformed with denaturation for 1 min at 988C, annealingRad) at a concentration of approximately 2 3 106/220 ml block, and
for 1 min at 608C, and extension for 3 min at 728C. Taq polymeraseDNA was extracted according to standard methods (Sambrook et
(10 U) was used in a total volume of 100 ml consisting of 50 mMal., 1989). Quarter blocks were digested with SacII, MluI, NotI,
KCl, 10 mM Tris (pH 9), 2 mM MgCl2, 0.1% Triton X-100, and 200BssHII, NruI, and SfiI under conditions recommended by the manu-
mM dNTP. The PCR products were electrophoresed on a 1% aga-facturer (New England BioLabs). Electrophoresis was carried out
rose gel, in order to determine their size, and subsequently clonedwith the Bio-Rad CHEF DR II apparatus, using 1% agarose gels run
into the pGEM T vector (Promega) by a shotgun procedure.for 20 hr at 200 V with a pulse time of 75 s. For higher resolution of
For sequence-sampling the ends of chromosome 9, specific cos-fragments under 500 kb, a 25 s pulse time was used. Transfer to
mids or cosmid subclones were directly sequenced (Smith et al.,nylon membranes (Du Pont Gene Screen Plus) was performed ac-
1994). Sequencing was performed on an ABI 373 DNA sequencer.cording to the instructions of the manufacturer after exposure of
The resulting end sequences were manually trimmed, examined forthe gel to UV (6±7 mW/cm2) for 2 min. Probes were labeled to a
simple sequence repeats, and used to search the DNA sequencespecificactivity of approximately 109 DPM/mg with [a-32P]dCTP (Am-
databases. Both nucleotide and amino acid searches were per-ersham) by the random primed synthesis method (Boehringer Mann-
formed. In addition, sequences were examined for potential codingheim Kit). Hybridization was carried out for 18 hr at 658C in 0.5 M
regions by GRAIL (Uberbacher and Mural, 1991).sodium phosphate (pH 7.2), 7% SDS, 1% BSA, 1 mM EDTA, and
Short cDNA fragments obtained by the methods outlined above200 mg/ml herring sperm DNA. For probes containing repetitive se-
were extended by screening brain or epidermal cDNA libraries andquences, sheared sonicated human placental DNA (Sigma) was
by rapid amplification of cDNA ends (Marathon Kit, Clontech).added to the hybridization solution (500 mg/ml) and preassociated
with the probe at 658C for 45 min prior to hybridization to the filter.
Intron/Exon Structure of the Human PTC GeneFilters were washed in 0.13 SSC with 1% SDS at 658C and exposed
Oligonucleotides were chosen at approximately 150 bp intervalsto autoradiographic film with an intensifying screen at 2708C from
spanning the cDNA of the human PTC gene. PCR products were12 hr to 3 days. Probes that detected similar sized fragments on
generated from cosmids 226G7, 42H11, 55A16 or 96F9. Reactionsdifferent blots were directly compared for comigrating fragments
were performed in a 50 ml volume containing 25 pmol of variousby hybridization to the same blot. Blots were stripped in 0.4 N NaOH
oligonucleotide combinations, 200 mmol dNTPs, 1.5 mM or 1.85 mMfor 30 min at room temperature between uses.
or 2.2 mM MgCl2, 5 U Taq polymerase, and amplified for 35 cycles
of 948C for 30 s, 558C for 30 s, and 728C for 2.5 min. Some samplesFISH
were amplified by long range PCR using the Expand Long TemplateCosmid clones were labeled by nick translation with biotin-11-dUTP,
PCR system (Boehringer Mannheim) according to the instructionsdigoxigenin-11-dUTP, or both, and hybridized to metaphase and
of the manufacturer. PCR products were resolved on a 1% agaroseinterphase chromosomes under suppression conditions. Biotinyl-
gel and isolated by a DNA purification kit (Jetsorb, Genomed). Se-ated probes were detected with 5 mg/ml FITC-conjugated avidin
quencing of PCR fragments was performed with the Taq DyedeoxyDCS. Digoxigenin-labeled probes were detected with 2 mg/ml anti-
Terminator Cycle Sequencing Kit (Applied Biosystems). Sequencing
digoxigenin Fab, conjugated to rhodamine. The chromosomes were
reactions were resolved on an ABI 373A automated sequencer.
counterstained with 200 ng/ml of DAPI. Images were obtained using
Positions of introns were determined by predicted splice donor or
a microscope coupled to a cooled CCD camera. The digitalized splice acceptor sites.
images were processed, pseudocolored, and merged, and the dis-
tances between signals were measured. Mutation Detection
A combined SSCP (Orita et al., 1989) and heteroduplex analysis
Cosmid and BAC Screening (White et al., 1992) approach was used under optimized conditions
A gridded chromosome 9 cosmid library (LL09NC01) was replicated (GlavacÆ and Dean, 1993). DNA samples (100 ng) were amplified in
onto nylon filters (Du Pont Gene Screen Plus) and screened ac- PCR buffer containing 1.5 mM MgCl2 and [a-32P]dCTP for 35 cycles
cording to the recommendations of the Human Genome Center, of 948C for 30 s, 558C for 30 s, and 728C for 30 s. Products were
Lawrence Livermore National Laboratory (J. Alleman, J. Garnes, diluted 1:3 in stop solution, denatured at 958C for 2 min, and 3 ml
J. McNinch, B. S. Wong, P. J. deJong, personal communication). loaded directly on gels. Gel formulations used were the following:
Positive clones were streaked out to single colonies and confirmed first, 6% acrylamide:Bis (2.6% cross-linking), 10% glycerol at room
to contain the appropriate markersby PCR or hybridization. Gridded temperature, 45 W; second, 6% acrylamide:Bis (2.6% cross-linking)
BAC filters were screened by hybridization according to the recom- at 48C, 60 W; third, 10% acrylamide:Bis (1.3% cross-linking), 10%
mendations of the manufacturer (Research Genetics). Because of glycerol at 48C,60 W; fourth, 0.53 MDE (ATGC Corporation, Malvern,
thesmall chance of chimerism in cosmids and BACs, fragments from PA), 10% glycerol at 48C, 50 W. Gels were run for 3±16 hr (3000 Vh/
the ends of contigs were mapped with a panel of human±hamster 100 bp), dried, and exposed to X-ray film for 2±24 hr. Heteroduplexes
somatic cell hybrids to confirm their localization on chromosome were identified from the double-stranded DNA at the bottom of the
9q22. gels, and SSCPs were identified from the single-stranded region.
Samples showing variation were compared with other family
Isolation of cDNAs members to assess segregation of the alleles, or with normal DNA
We used four methods to isolate candidate cDNAs. Direct cDNA from the same patient in the case of tumors. PCR products with
selection (Parimoo et al., 1991) was applied to pools of cosmids SSCP or heteroduplex variants were treated with shrimp alkaline
and BACs. Following two rounds of selection, the PCR products phosphatase and exonuclease I (United States Biochemical) and
were size-fractionated and cloned into PCRII (Invitrogen). Trans- cycle-sequenced with AmplitaqFS (Perkin Elmer). The products
formants were gridded into 96-well plates, and replica filters were were analyzed on an Applied Biosystems model 373A DNA se-
probed with the genomic template DNA to identify cDNAs that hy- quencer.
bridized the correct genomic region.
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